Nexstim Adds $2.87M

Nexstim Oy, a medical device company focused on non-invasive brain diagnostic and therapy technologies, has added 2 million euro ($2.87 million) to bring its latest round to 13.4 million euro. Belgium-based Capricorn Health-tech Fund NV provided the latest tranche, joining shareholders including HealthCap Life Sciences Partners, Sitra and Finnish Industry Investment Ltd, as well as Lundbeckfond Ventures and Ilmarinen. To date, Nexstim has raised more than 30 million euros. The company is based in Finland.

North AmericaUSBriefs